|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,003.00 GBX | +1.01% |
|
+1.11% | +9.78% |
| 07-07 | Stocks mixed as weak miners weigh in muted trade | AN |
| 07-06 | HSBC Upgrades GSK to Hold Rating, Boosts PT | MT |
| Market Cap | 79.81B 107B 93.39B 86.11B 151B 10,124B 154B 1,033B 400B 4,990B 400B 391B 17,277B | P/E 2026 * |
12.7x | P/E 2027 * | 11.7x |
|---|---|---|---|---|---|
| Enterprise Value | 95.24B 127B 111B 103B 180B 12,081B 184B 1,232B 477B 5,955B 477B 467B 20,617B | EV / Sales 2026 * |
2.81x | EV / Sales 2027 * | 2.59x |
| Free-Float |
92.29% | Yield 2026 * |
3.51% | Yield 2027 * | 3.7% |
Last Transcript: GSK plc
| 1 day | +1.01% | ||
| 1 week | +1.11% | ||
| Current month | +1.11% | ||
| 1 month | +4.70% | ||
| 3 months | -4.44% | ||
| 6 months | +5.34% | ||
| Current year | +9.78% |
| 1 week | 1,930 |  | 2,049 |
| 1 month | 1,839 | | 2,049 |
| Current year | 1,690 | | 2,282 |
| 1 year | 1,288.6 | | 2,282 |
| 3 years | 1,242.5 | | 2,282 |
| 5 years | 1,242.5 | | 3,408.16 |
| 10 years | 1,242.5 | | 3,408.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | - | 01/01/2026 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 01/05/2023 |
| Chief Tech/Sci/R&D Officer | - | 01/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | - | 06/05/2026 |
Hal Barron
BRD | Director/Board Member | 64 | 01/01/2018 |
Jonathan Symonds
CHM | Chairman | 68 | 01/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-22 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| 06-08 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| 05-22 | Buy | Executive/Senior Manager | 9 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.01% | +1.11% | +43.53% | +52.20% | 106B | |
| +2.96% | +3.01% | +59.87% | +173.31% | 1,070B | |
| +3.05% | +5.23% | +72.11% | +67.81% | 624B | |
| -0.04% | +1.20% | +35.72% | +87.93% | 450B | |
| -2.58% | -2.07% | +27.62% | +22.57% | 328B | |
| +1.36% | +0.17% | +29.90% | +49.33% | 284B | |
| +1.98% | +4.08% | -25.78% | -39.02% | 217B | |
| +0.45% | +1.65% | +25.65% | +68.35% | 198B | |
| +5.21% | +7.93% | +21.99% | +83.23% | 161B | |
| +1.48% | -0.04% | -4.64% | -32.25% | 135B | |
| Average | +0.88% | +2.00% | +28.60% | +53.35% | 357.3B | |
| Weighted average by Cap. | +0.31% | +2.44% | +41.90% | +86.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.86B 45.2B 39.62B 36.54B 64.17B 4,295B 65.27B 438B 170B 2,117B 170B 166B 7,330B | 35.59B 47.51B 41.64B 38.4B 67.45B 4,514B 68.6B 461B 178B 2,225B 178B 174B 7,704B |
| Net income | 6.47B 8.64B 7.57B 6.98B 12.27B 821B 12.48B 83.76B 32.41B 405B 32.44B 31.74B 1,401B | 6.94B 9.26B 8.12B 7.49B 13.15B 880B 13.37B 89.79B 34.74B 434B 34.77B 34.02B 1,502B |
| Net Debt | 15.43B 20.6B 18.06B 16.65B 29.24B 1,957B 29.74B 200B 77.27B 965B 77.32B 75.66B 3,340B | 12.24B 16.33B 14.32B 13.2B 23.19B 1,552B 23.59B 158B 61.27B 765B 61.32B 59.99B 2,649B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/07/26 | GBX 2,003.00 | +1.01% | 4,183,855 |
| 06/07/26 | GBX 1,983.00 | -1.59% | 15,158,597 |
| 03/07/26 | GBX 2,015.00 | +0.55% | 2,548,759 |
| 02/07/26 | GBX 2,004.00 | +3.83% | 17,567,408 |
| 01/07/26 | GBX 1,930.00 | -2.57% | 8,818,924 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
